Company / Gross Profit per Share
Ernexa Therapeutics Inc. Gross Profit per Share History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Profit per Share
$0.14
FY2025
5-year range
-$0.03 / $0.14
FY2023-FY2025
Trend
+556.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $0.00 to $0.14 over the past 2 years.
Based on SEC 10-K filings.
0.14 in FY2025.
Improved from $0.00 to $0.14 over the past 2 years.
Gross Profit per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, gross profit per share increased 556.8% year-over-year.
Company context
Key Data Points
- Altman Z-Score -8.07 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross Profit per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.14 | +556.8% |
| FY2024 | -$0.03 | - |
| FY2023 | $0.00 | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
| FY2015 | - | - |
| FY2014 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026